by canyonlabsstg | Aug 19, 2025 | Events
Introduction Sensitization testing is designed to rule out the potential for allergic reactions that can result from exposure to a medical device, material, or pharmaceutical product. These delayed hypersensitivity reactions can occur when the body’s immune system...
by canyonlabsstg | Jul 29, 2025 | Events
Executive Summary In today’s dynamic regulatory and supply chain landscape, more medical device and pharmaceutical manufacturers are exploring changes to their sterilization methods. These shifts are often driven by growing environmental concerns, evolving regulatory...
by canyonlabsstg | Jul 23, 2025 | Events
Building Confidence in NAMs Through Integration New Approach Methodologies (NAMs)—ranging from in vitro assays to computational models—offer promising alternatives to traditional animal testing. However, their widespread adoption hinges on confidence in their...
by canyonlabsstg | Jul 9, 2025 | Events
Pyrogens are toxins, often derived from chemicals or bacteria, that can trigger fever when introduced into the body. These substances pose significant risks to patient health, making their detection a vital step in evaluating the safety of medical devices and...
by Thomas Moore | Jun 27, 2025 | Events
Cytotoxicity testing is a standard procedure used to evaluate the potential toxicity of medical devices at the cellular level. The term "cyto" refers to cells, and this type of testing examines whether a device or its materials could be “toxic” by inhibiting cell...
by canyonlabsstg | Apr 4, 2025 | Events
At Canyon Labs, we pride ourselves on delivering world-class validation testing and consulting services to the medical device and pharmaceutical markets. With the recent acquisition of iuvo BioScience’s preclinical lab and consulting services, we are excited to...
